These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 2554111)

  • 21. Properties of two classes of rat brain acidic amino acid receptors induced by distinct mRNA populations in Xenopus oocytes.
    Fong TM; Davidson N; Lester HA
    Synapse; 1988; 2(6):657-65. PubMed ID: 2905539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.
    Lester RA; Quarum ML; Parker JD; Weber E; Jahr CE
    Mol Pharmacol; 1989 May; 35(5):565-70. PubMed ID: 2566902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
    Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
    Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
    Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
    Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds.
    Schmieden V; Jezequel S; Betz H
    Mol Pharmacol; 1996 Nov; 50(5):1200-6. PubMed ID: 8913351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
    Zhong J; Gribkoff VK; Molinoff PB
    Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of the NMDA receptor glycine site to rhythm generation during fictive swimming in Xenopus laevis tadpoles.
    Issberner JP; Sillar KT
    Eur J Neurosci; 2007 Nov; 26(9):2556-64. PubMed ID: 17970719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-Serine inhibits AMPA receptor-mediated current in rat hippocampal neurons.
    Gong XQ; Zabek RL; Bai D
    Can J Physiol Pharmacol; 2007 May; 85(5):546-55. PubMed ID: 17632590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.
    Miyazaki J; Nakanishi S; Jingami H
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):687-92. PubMed ID: 10359652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogues of gamma-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists.
    Chebib M; Vandenberg RJ; Johnston GA
    Br J Pharmacol; 1997 Dec; 122(8):1551-60. PubMed ID: 9422798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo.
    Hama Y; Katsuki H; Tochikawa Y; Suminaka C; Kume T; Akaike A
    Neurosci Res; 2006 Nov; 56(3):279-85. PubMed ID: 16934894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate recognition by the mammalian proton-dependent amino acid transporter PAT1.
    Boll M; Foltz M; Anderson CM; Oechsler C; Kottra G; Thwaites DT; Daniel H
    Mol Membr Biol; 2003; 20(3):261-9. PubMed ID: 12893527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anesthetic-like modulation of a gamma-aminobutyric acid type A, strychnine-sensitive glycine, and N-methyl-d-aspartate receptors by coreleased neurotransmitters.
    Milutinovic PS; Yang L; Cantor RS; Eger EI; Sonner JM
    Anesth Analg; 2007 Aug; 105(2):386-92. PubMed ID: 17646495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site.
    Romano C; Williams K; DePriest S; Seshadri R; Marshall GR; Israel M; Molinoff PB
    Mol Pharmacol; 1992 Apr; 41(4):785-92. PubMed ID: 1533270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.